Black Diamond Therapeutics, Inc. (BDTX) vs PolyPid Ltd. (PYPD)
A side-by-side comparison of Black Diamond Therapeutics, Inc. and PolyPid Ltd. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BDTX
Black Diamond Therapeutics, Inc.
$1.80HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
PYPD
PolyPid Ltd.
$5.13HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — BDTX vs PYPD
growth of $100 · dividends reinvested · last 6yBDTX -95.6% (-40.6%/yr)PYPD -99.1% (-54.3%/yr)BDTX compounded faster over this window
BDTX PYPD
BDTX vs PYPD: by the numbers
- •BDTX is the larger company ($103M vs $98M market cap).
- •BDTX is profitable (31.95% net margin) while PYPD runs a net loss (0.00%).
Metrics side by side
Valuation
| Metric | BDTX | PYPD |
|---|---|---|
| P/B ratio | 1.07 | 18.17 |
Profitability
| Metric | BDTX | PYPD |
|---|---|---|
| Gross margin | 99.54% | 0.00% |
| Operating margin | 28.39% | 0.00% |
| Net margin | 31.95% | 0.00% |
| ROE | -44.29% | -584.65% |
| ROIC | -47.54% | 13.49% |
Growth (annualized)
| Metric | BDTX | PYPD |
|---|---|---|
| Total return CAGR (5Y) | -24.47% | -52.69% |
Frequently asked
- Is BDTX or PYPD more profitable?
- BDTX runs the higher net margin — BDTX at 31.95% versus PYPD at 0.00%.
- How have BDTX and PYPD total returns compared?
- Over the past 5 years, BDTX delivered -24.47% and PYPD delivered -52.69% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.